About Brian Moran Cancer Institute

The Bri­an Moran Can­cer Insti­tute was named in hon­or of Bri­an J. Moran, MD (1960 – 2024), a vision­ary physi­cian, teacher, and leader whose life’s work helped shape can­cer care in the Chica­go area and beyond.

For more than three decades, Dr. Moran ded­i­cat­ed his career to improv­ing out­comes and expand­ing access to advanced, com­pas­sion­ate can­cer treat­ment. A board-cer­ti­fied radi­a­tion oncol­o­gist, he was inter­na­tion­al­ly rec­og­nized for his exper­tise in prostate brachyther­a­py and for pio­neer­ing new approach­es that helped count­less patients live longer, health­i­er lives.

At Duly Health and Care, Dr. Moran was more than a physi­cian; he was an advo­cate for patients and a men­tor to col­leagues. His belief that excep­tion­al care should be acces­si­ble to every per­son con­tin­ues to guide the mis­sion of the Can­cer Insti­tute that bears his name.

The Bri­an Moran Can­cer Insti­tute reflects his lega­cy of inno­va­tion, col­lab­o­ra­tion, and human­i­ty. Through mul­ti­dis­ci­pli­nary care, lead­ing-edge treat­ments, and a stead­fast focus on the patient expe­ri­ence, we car­ry for­ward Dr. Moran’s vision of bring­ing aca­d­e­m­ic-lev­el can­cer care clos­er to home, deliv­ered with com­pas­sion and purpose.

Bri­an Moran Can­cer Insti­tute Leadership

Bri­an Myre, MD
Direc­tor, Bri­an Moran Can­cer Institute

Dr. Bri­an Myre serves as Direc­tor of the Bri­an Moran Can­cer Insti­tute, over­see­ing med­ical, sur­gi­cal, and radi­a­tion oncol­o­gy ser­vice lines, as well as the Institute’s clin­i­cal research programs.

Dr. Myre is a med­ical oncol­o­gist spe­cial­iz­ing in gen­i­touri­nary (GU) can­cers — includ­ing prostate, blad­der, kid­ney, and tes­tic­u­lar can­cers — as well as tho­racic malignancies.

He earned his med­ical degree from the Med­ical Col­lege of Wis­con­sin and com­plet­ed his inter­nal med­i­cine res­i­den­cy and hematology/​oncology fel­low­ship at Indi­ana University.

Samir Desai, MD
Chair­man, Med­ical Oncology

Dr. Samir Desai serves as Chair­man of Med­ical Oncol­o­gy, over­see­ing the med­ical oncol­o­gy ser­vice line across all five Insti­tute sites.

He spe­cial­izes in breast, gas­troin­testi­nal (GI), gen­i­touri­nary (GU), and tho­racic can­cers, as well as benign and malig­nant hema­to­log­ic conditions.

Dr. Desai earned his med­ical degree from North­east­ern Ohio Uni­ver­si­ty, com­plet­ed his inter­nal med­i­cine res­i­den­cy at Sum­ma Akron City Hos­pi­tal, and com­plet­ed his hematology/​oncology fel­low­ship at Brown Uni­ver­si­ty.
 

Daniel Frank, MD
Vice Chair­man, Med­ical Oncology

Dr. Daniel Frank serves as Vice Chair­man of Med­ical Oncol­o­gy, sup­port­ing coor­di­nat­ed, patient-cen­tered oncol­o­gy care across the Institute.

He spe­cial­izes in breast and gas­troin­testi­nal (GI) can­cers, as well as benign and malig­nant hema­to­log­ic conditions.

Dr. Frank earned his med­ical degree from North­west­ern Uni­ver­si­ty, com­plet­ed his inter­nal med­i­cine res­i­den­cy at the Uni­ver­si­ty of Wis­con­sin, and com­plet­ed his hematology/​oncology fel­low­ship at the Uni­ver­si­ty of Wis­con­sin Hos­pi­tal and Clin­ics.
 

Anand Shah, MD
Chair­man, Radi­a­tion Oncology 

Dr. Anand Shah serves as Chair­man of Radi­a­tion Oncol­o­gy, lead­ing the devel­op­ment and deliv­ery of advanced radi­a­tion ther­a­py ser­vices across the Institute.

He spe­cial­izes in radi­a­tion treat­ment for prostate, blad­der, lung, and head and neck cancers.

Dr. Shah earned his med­ical degree from North­west­ern Uni­ver­si­ty Med­ical School, earned a Mas­ter of Sci­ence in med­ical physics from Rush Uni­ver­si­ty, and com­plet­ed his radi­a­tion oncol­o­gy res­i­den­cy at Rush Uni­ver­si­ty Med­ical Cen­ter, where he served as chief res­i­dent.
 

Amit Patel, MD
Direc­tor of Sur­gi­cal Ser­vices, Bri­an Moran Can­cer Institute 

Dr. Amit Patel serves as Direc­tor of Sur­gi­cal Ser­vices at the Bri­an Moran Can­cer Insti­tute and Co-Chair­man of Urol­o­gy at Duly Health and Care.

He spe­cial­izes in the sur­gi­cal man­age­ment of gen­i­touri­nary (GU) can­cers — includ­ing prostate, blad­der, kid­ney, and tes­tic­u­lar can­cers — with exper­tise in min­i­mal­ly inva­sive inter­ven­tions, includ­ing robot­ic surgery and focal therapy.

Dr. Patel earned his med­ical degree from The Ohio State Uni­ver­si­ty, com­plet­ed his intern­ship and urol­o­gy res­i­den­cy at the Cleve­land Clin­ic (where he served as Chief Res­i­dent), and com­plet­ed a fel­low­ship in uro­log­ic oncol­o­gy at the Uni­ver­si­ty of Chica­go.